Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Barclays Maintains Underweight on II-VI, Lowers Price Target to $47

Author: Benzinga Newsdesk | July 25, 2022 07:03am
Barclays analyst Tom O'Malley maintains II-VI (NASDAQ:IIVI) with a Underweight and lowers the price target from $65 to $47.

Posted In: IIVI

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist